Regentatlantic Capital LLC Abbott Laboratories Transaction History

Regentatlantic Capital LLC

$3.34 Billion
Q3 2022

A detailed history of Regentatlantic Capital LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Regentatlantic Capital LLC holds 84,462 shares of ABT stock, worth $9.49 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

84,462

Previous 91,594 7.79%

Holding current value

$9.49 Million

Previous $9.95 Million 17.88%

% of portfolio

0.24%

Previous 0.33%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $690,092 - $798,997	-7,132 Reduced 7.79%	84,462 $8.17 Million
Q2 2022 Aug 15, 2022	BUY	$102.07 - $123.37 $13,371 - $16,161	131 Added 0.14%	91,594 $9.95 Million
Q1 2022 May 02, 2022	BUY	$114.02 - $139.04 $141,498 - $172,548	1,241 Added 1.38%	91,463 $10.8 Million
Q4 2021 Jan 27, 2022	BUY	$115.53 - $141.46 $182,768 - $223,789	1,582 Added 1.78%	90,222 $12.7 Million
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $892,915 - $987,825	7,654 Added 9.45%	88,640 $10.5 Million
Q2 2021 Aug 12, 2021	BUY	$105.79 - $124.53 $386,345 - $454,783	3,652 Added 4.72%	80,986 $9.39 Million
Q1 2021 Apr 29, 2021	BUY	$108.84 - $128.23 $1.54 Million - $1.82 Million	14,191 Added 22.47%	77,334 $9.27 Million
Q4 2020 Feb 04, 2021	BUY	$105.0 - $114.42 $782,775 - $853,001	7,455 Added 13.39%	63,143 $6.91 Million
Q3 2020 Oct 13, 2020	BUY	$91.64 - $111.29 $377,373 - $458,292	4,118 Added 7.99%	55,688 $6.06 Million
Q2 2020 Aug 13, 2020	BUY	$76.57 - $98.0 $557,812 - $713,930	7,285 Added 16.45%	51,570 $4.72 Million
Q1 2020 May 14, 2020	SELL	$62.82 - $91.86 $2.2 Million - $3.22 Million	-35,082 Reduced 44.2%	44,285 $3.5 Million
Q4 2019 Feb 04, 2020	SELL	$78.51 - $87.4 $39,097 - $43,525	-498 Reduced 0.62%	79,367 $6.89 Million
Q3 2019 Oct 22, 2019	SELL	$81.84 - $88.74 $49,922 - $54,131	-610 Reduced 0.76%	79,865 $6.68 Million
Q2 2019 Jul 23, 2019	BUY	$72.88 - $85.0 $107,425 - $125,290	1,474 Added 1.87%	80,475 $6.77 Million
Q1 2019 May 03, 2019	BUY	$66.22 - $80.06 $294,943 - $356,587	4,454 Added 5.97%	79,001 $6.32 Million
Q4 2018 Jan 30, 2019	BUY	$65.56 - $74.27 $2.23 Million - $2.53 Million	34,071 Added 84.18%	74,547 $5.39 Million
Q3 2018 Oct 30, 2018	BUY	$60.81 - $73.36 $59,289 - $71,526	975 Added 2.47%	40,476 $2.97 Million
Q2 2018 Jul 31, 2018	SELL	$57.57 - $63.54 $29,418 - $32,468	-511 Reduced 1.28%	39,501 $2.41 Million
Q1 2018 Apr 23, 2018	SELL	$56.27 - $63.62 $58,014 - $65,592	-1,031 Reduced 2.51%	40,012 $2.4 Million
Q4 2017 Jan 23, 2018	SELL	$53.68 - $57.47 $31,295 - $33,505	-583 Reduced 1.4%	41,043 $2.34 Million
Q3 2017 Oct 25, 2017	BUY	$48.06 - $53.64 $2 Million - $2.23 Million	41,626	41,626 $2.22 Million

Others Institutions Holding ABT

# of Institutions

3,189

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Regentatlantic Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regentatlantic Capital LLC with notifications on news.

Account

Regentatlantic Capital LLC Abbott Laboratories Transaction History